See All Slides - tctmd.com

Slides

Presentation TCT 2013

Recognition and Treatment of Paravalvular AR

Presenter: Massimo Napodano

October 30, 2013

Presentation TCT 2013

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

Presenter: Fernando Alfonso

October 30, 2013

Presentation TCT 2013

Treatment of Juxtarenal and Pararenal AAA: Endovascular Options in 2013

Presenter: Jason Lee

October 30, 2013

Presentation TCT 2013

Case #4 - Rescue Rotablation in a Patient with ACS and Cardiogenic Shock

Presenter: Johann Sipoetz

October 30, 2013

Presentation TCT 2013

2013 Concepts of Plaque Progression, Expansion, Rupture, and Thrombosis

Presenter: Renu Virmani

October 30, 2013

Presentation TCT 2013

Problem Statement: The Good, the Bad, and the Ugly of Clinical Research in 2013

Presenter: Mitchell Krucoff

October 30, 2013

Presentation TCT 2013

Pre-load wtih Platelet ADP Receptor Inhibition in STEMI: Prasugrel, Ticagrelor, Clopidogrel, Or Does it Matter?

Presenter: Michel Le May

October 30, 2013

Presentation TCT 2013

ACCESS EU Insights: Are the Randomized Trial Results Translatable?

Presenter: Olaf Franzen

October 30, 2013

Presentation TCT 2013

Navigating the Stent Era (from Bare Metal to Drug-Eluting): The Transformation of PCI

Presenter: Patrick Serruys

October 30, 2013

Presentation TCT 2013

Role of EVAR in the Treatment of Ruptured AAA

Presenter: Christopher Zarins

October 30, 2013

Advertisement

Slides

Recognition and Treatment of Paravalvular AR

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

Treatment of Juxtarenal and Pararenal AAA: Endovascular Options in 2013

Case #4 - Rescue Rotablation in a Patient with ACS and Cardiogenic Shock

2013 Concepts of Plaque Progression, Expansion, Rupture, and Thrombosis

Problem Statement: The Good, the Bad, and the Ugly of Clinical Research in 2013

Pre-load wtih Platelet ADP Receptor Inhibition in STEMI: Prasugrel, Ticagrelor, Clopidogrel, Or Does it Matter?

ACCESS EU Insights: Are the Randomized Trial Results Translatable?

Navigating the Stent Era (from Bare Metal to Drug-Eluting): The Transformation of PCI

Role of EVAR in the Treatment of Ruptured AAA

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content